Pure Global AI
NCT06395649Recruiting

Personalized Treatment by rTMS in Chronic Pain

Personalized Pain Treatment by Transcranial Magnetic Stimulation in Patients With Chronic Pain: a Study on Mechanisms
Aalborg UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Chronic Pain
Drug/Device/Intervention
Classical rTMS to M1
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Aalborg University
Location
Gistrup, Denmark
Timeline & enrollment
Phase
N/A
Start date
May 15, 2024
End date
Dec 31, 2028
Enrollment
90 participants
Primary outcome

Pain intensity (Visual analogue scale)

Summary

Previous research has shown the effectiveness of magnetic stimulation of the brain as a
 supplemental treatment for various conditions, such as depression and chronic pain. However,
 the application of magnetic stimulation has been standardized across patients without
 considering individual differences. This one-size-fits-all approach results in only half of
 the patients benefiting from the treatment, with the other half seeing no improvement in
 their symptoms. Therefore, a study on individuals with chronic pain will be performed to
 explore how magnetic stimulation treatments can be tailored to each person. This will involve
 analyzing brain signal measurements before the start of the therapy and
 adjusting/personalizing the magnetic stimulations to each individual person.

ICD-10 classifications
Other chronic painChronic intractable painPain, not elsewhere classifiedPain, unspecifiedPain associated with micturition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06395649
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06395649 through Pure Global AI's free database. This phase not specified trial is sponsored by Aalborg University and is currently Recruiting. The study focuses on Chronic Pain. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.